According to Wuzhou Medical's announcement, the cumulative deviation value of the company's stock price increase reached 30.22% for two consecutive trading days on August 7 and August 10, 2026, which is an abnormal fluctuation. As of August 10, the company's dynamic and static price-earnings ratios were 194.03 times and 330.73 times respectively, which was significantly higher than the industry average. The company operates normally. Other than the disclosed acquisition plan, no undisclosed matters should be disclosed. Remind investors to pay attention to acquisition risks, price-earnings ratio differences and semi-annual report disclosures, and invest rationally.

According to Wuzhou Medical's announcement, the cumulative deviation value of the company's stock price increase reached 30.22% for two consecutive trading days on August 7 and August 10, 2026, which is an abnormal fluctuation. As of August 10, the company's dynamic and static price-earnings ratios were 194.03 times and 330.73 times respectively, which was significantly higher than the industry average. The company operates normally. Other than the disclosed acquisition plan, no undisclosed matters should be disclosed. Remind investors to pay attention to acquisition risks, price-earnings ratio differences and semi-annual report disclosures, and invest rationally.